An2 Therapeutics, Inc.
ANTX
Revenue
0.00
0.000.00%
-Assets
67.24M
▼-8.59M▼-11.33%
3 Months ChangeLiabilities
6.86M
▼-125.00k▼-1.79%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-29
Form 8-K
ID: 0001193125-26-029540
2025-11-12
Form 10-Q
ID: 0001193125-25-277673
2025-11-12
Form 8-K
ID: 0001193125-25-277662
2025-08-12
Form 10-Q
ID: 0000950170-25-107301
2025-08-12
Form 8-K
ID: 0000950170-25-107278
2025-06-20
Form 8-K
ID: 0001193125-25-143187
2025-06-11
Form 8-K
ID: 0001193125-25-138796
2025-05-27
Form 8-K
ID: 0001193125-25-127595
2025-05-13
Form 10-Q
ID: 0000950170-25-070358
2025-05-13
Form 8-K
ID: 0000950170-25-070305